VPC
Vestal Point Capital Portfolio holdings
AUM
$1.9B
1-Year Est. Return
12.28%
1 Year Est. Return
-12.28%
AUM
$1.9B
AUM Growth
+$499M
(+36%)
Holding
85
Top Buys
| 1 | +$127M | |
| 2 | +$46.3M | |
| 3 | +$44.1M | |
| 4 |
Amicus Therapeutics
FOLD
|
+$43.7M |
| 5 |
Exact Sciences
EXAS
|
+$37.2M |
Top Sells
| 1 | +$82M | |
| 2 | +$23.8M | |
| 3 | +$18.1M | |
| 4 |
Liquidia Corp
LQDA
|
+$18.1M |
| 5 |
Establishment Labs
ESTA
|
+$17.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Savara
SVRA
$754M
| $25.1M | 1.32% |
11,015,000
+15,000
|
|
||
27
Cooper Companies
COO
$14.6B
| $24.9M | 1.31% |
+350,000
|
|
||
28
Structure Therapeutics
GPCR
$1.52B
| $24.9M | 1.31% |
1,200,000
-588,990
|
|
||
29
Cidara Therapeutics
CDTX
$2.36B
| $24.4M | 1.28% |
500,000
-4,542
|
|
||
30
Astria Therapeutics
ATXS
$702M
| $24.2M | 1.28% |
4,522,000
+342,000
|
|
||
31
Abbott
ABT
$221B
| $23.8M | 1.25% |
+175,000
|
|
||
32
Edwards Lifesciences
EW
$44.7B
| $23.5M | 1.24% |
+300,000
|
|
||
33
Nurix Therapeutics
NRIX
$853M
| $22.8M | 1.2% |
2,000,000
+874,448
|
|
||
34
Cogent Biosciences
COGT
$2.11B
| $22.1M | 1.16% |
3,080,000
+80,000
|
|
||
35
Bruker
BRKR
$5.92B
| $20.6M | 1.08% |
500,000
+200,000
|
|
||
36
Ionis Pharmaceuticals
IONS
$11.3B
| $19.8M | 1.04% |
+500,000
|
|
||
37
Day One Biopharmaceuticals
DAWN
$767M
| $19.5M | 1.03% |
3,000,000
+401,873
|
|
||
38
Medtronic
MDT
$120B
| $17M | 0.89% |
+195,000
|
|
||
39
Perrigo
PRGO
$2.95B
| $16.7M | 0.88% |
625,000
+37,351
|
|
||
40
Zymeworks
ZYME
$1.34B
| $14.4M | 0.76% |
1,150,000
+650,000
|
|
||
41
Black Diamond Therapeutics
BDTX
$224M
| $13.9M | 0.73% |
5,600,000
|
|
||
42
Lexeo Therapeutics
LXEO
$643M
| $13M | 0.68% |
3,228,161
+2,091,912
|
|
||
|
NYXH
43
Nyxoah
NYXH
$211M
| $10.5M | 0.55% |
1,402,002
-916,952
|
|
||
44
Thermo Fisher Scientific
TMO
$216B
| $10.1M | 0.53% |
+25,000
|
|
||
45
Danaher
DHR
$158B
| $9.88M | 0.52% |
50,000
-75,000
|
|
||
|
BBNX
46
Beta Bionics
BBNX
$911M
| $8.01M | 0.42% |
+550,000
|
|
||
47
Disc Medicine
IRON
$2.98B
| $7.41M | 0.39% |
+140,000
|
|
||
48
Solid Biosciences
SLDB
$438M
| $7.33M | 0.39% |
1,505,000
-248,558
|
|
||
49
Taysha Gene Therapies
TSHA
$1.3B
| $6.93M | 0.36% |
+3,000,000
|
|
||
50
Dyne Therapeutics
DYN
$2.44B
| $6.93M | 0.36% |
727,500
-1,072,500
|
|